Skip to main content
. 2019 Aug 19;84(4):849–860. doi: 10.1007/s00280-019-03914-2

Table 1.

Patient demographics (safety analysis population)

Pediatric solid tumor or pediatric brain tumor
N = 9
Adult malignant lymphoma
N = 10
Sex
 Female, n (%) 4 (44.4) 4 (40.0)
 Male, n (%) 5 (55.6) 6 (60.0)
Age, years
 Mean (SD) 7.0 (5.9) 53.7 (11.6)
 Median (min, max) 5.0 (2, 16) 54.5 (35, 68)
Height, cm, mean (SD) 114.3 (34.4) 164.7 (10.2)
Weight, kg, mean (SD) 23.0 (14.4) 60.0 (12.1)
Body surface area,a m2, mean (SD) 0.85 (0.40) 1.65 (0.20)
ECOG performance status,bn (%)
 0 4 (44.4) 7 (70.0)
 1 5 (55.6) 3 (30.0)
Primary malignancy, n (%)
 Pediatric solid tumor 4 (44.4) 0
 Pediatric brain tumor 5 (55.6) 0
 Malignant lymphoma 0 10 (100.0)
Relapse, n (%) 2 (22.2) 6 (60.0)
Number of previous HSCTs, n (%)
 0 6 (66.7) 10 (100.0)
 1 3 (33.3) 0
Patients with complicationsc 6 (66.7) 9 (90.0)

ECOG Eastern Cooperative Oncology Group, HSCT hematopoietic stem cell transplantation, SD standard deviation

aBody surface area is calculated as a function of age. If age was < 16 years, the Mosteller formula was used ([weight (kg) × height (cm)/3600]0.5). If age was ≥ 16 years, the DuBois formula was used ([weight (kg)0.425 × height (cm)0.725] × 0.007184)

bRange 0–4

cSee Supplementary Table S1 for full list of complications